Affiliation: Martin Luther University
- Cisplatin resistance and oncogenes--a reviewW Dempke
Department of Internal Medicine, Martin Luther University, Halle Saale, Germany
Anticancer Drugs 11:225-36. 2000....
- [Hemorrhagic diathesis as initial symptom of stomach carcinoma]W Dempke
Klinik für Innere Medizin IV Hämatologie und Onkologie, Martin Luther Universitat Halle Wittenberg, Halle Saale, Bundesrepublik Deutschland
Wien Klin Wochenschr 112:1053-8. 2000..Microangiopathic hemolytic anemia (MAHA) and disseminated intravasal coagulation (DIC) as initial paraneoplastic symptoms of a solid tumor present a rare clinical situation...
- Cyclooxygenase-2: a novel target for cancer chemotherapy?W Dempke
Department of Hematology and Oncology, Martin Luther University Halle Wittenberg, Halle Saale, Germany
J Cancer Res Clin Oncol 127:411-7. 2001..This may lead to new perspectives that by controlling the cancer phenotype, rather than attempting to eradicate all affected cells, may provide significant benefits to the cancer patient...
- [Possible new indications for erythropoietin therapy]W Dempke
Klinik für Innere Medizin IV Hämatologie und Onkologie, Martin Luther Universitat Halle Wittenberg
Med Klin (Munich) 96:467-74. 2001..Currently, new EPO derivatives, synthetic fusion proteins and gene therapeutic studies are under clinical investigation suggesting that the EPO-induced effects may be increased significantly by these agents in the future...
- Human hematopoietic growth factors: old lessons and new perspectivesW Dempke
Martin Luther University, Department of Hematology and Oncology, Ernst Grube Str 40, 06120 Halle Saale, Germany
Anticancer Res 20:5155-64. 2000..Preliminary results suggest that these compounds may have a major impact on the management of myeloablative chemotherapy because of their ability to enhance platelet recovery in addition to their neutrophil restorative activity...